# University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial

> **NCT02508259** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 10 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Suramin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02508259
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02508259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02508259, "University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02508259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*